Countdown to close
$
174.08
Change
-6.79 -3.75%
Volume
Volume 4.39m
Jan 31, 2023, 3:16 p.m.
Real time quotes
Previous close
$ 180.87
$ 174.08
Change
-6.79 -3.75%
Day low
Day high
$173.78
$180.21

52 week low
52 week high
$115.03
$217.25

Market cap
$69.49B
Average volume
5.11M
P/E ratio
6.30
Rev. per Employee
$7.86M
EPS
27.65
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on MRNA
-
Moderna Inc. stock underperforms Monday when compared to competitors
- MarketWatch Automation
-
Moderna Inc. stock falls Friday, underperforms market
- MarketWatch Automation
-
FDA Advisers Recommend Replacing All Covid Vaccines With Bivalent Version
- Josh Nathan-Kazis
-
Moderna Inc. stock rises Thursday, still underperforms market
- MarketWatch Automation
-
Moderna Inc. stock falls Wednesday, underperforms market
- MarketWatch Automation
-
Moderna Inc. stock falls Tuesday, still outperforms market
- MarketWatch Automation
-
Moderna Inc. stock rises Monday, still underperforms market
- MarketWatch Automation
-
An Annual Covid Booster Could Be Coming. What It Means for Pfizer, Moderna.
- Josh Nathan-Kazis
-
Moderna Inc. stock rises Friday, still underperforms market
- MarketWatch Automation
-
Moderna Inc. stock underperforms Thursday when compared to competitors
- MarketWatch Automation
-
Moderna Inc. stock outperforms competitors on strong trading day
- MarketWatch Automation
-
Chegg, Bluebird Bio, Yeti, J.B. Hunt, and More Market Movers
- Emily Dattilo
- Loading more headlines...
Other News on MRNA
-
How Biden Officials Bungled a Better Vaccine
- Allysia Finley
-
FDA Advisers Back Annual Covid-19 Boosters With Reservations About Rollout
- Liz Essley Whyte
-
Top 5 4th Quarter Trades of ARS Investment Partners, LLC
- GuruFocus.com
-
Baillie Gifford Slashes Meta, Boosts Nvidia
- GuruFocus.com
-
Johnson & Johnson Profit Falls 25%
- Peter Loftus
-
The Deceptive Campaign for Bivalent Covid Boosters
- Allysia Finley
-
Stocks Fall After Retail and Inflation Data
- Joe Wallace
-
Moderna Finds Life After Covid-19
- David Wainer
-
A New U.S. Law Aims to Reduce Drug Prices. But First, It Might Raise Them
- Jared S. Hopkins
-
J&J Slashes Production of Its Covid-19 Vaccine
- Jared S. Hopkins
-
Aurora Investment Managers, LLC. Buys 3, Sells 2 in 4th Quarter
- GuruFocus.com
-
Old Port Advisors Buys 3, Sells 2 in 4th Quarter
- GuruFocus.com
-
Moderna Considers Price of $110-$130 for Covid-19 Vaccine
- Peter Loftus
-
China to Allow Rapid Tests to Confirm Covid Cases
- Rachel Liang
-
Corporate Insiders Aren’t Betting on a Market Rebound
- Jack Pitcher
-
Western Covid Medicine to China’s Rescue
- The Editorial Board
-
Boring Was King of Healthcare in 2022
- David Wainer
- Loading more headlines...
Press Releases on MRNA
-
Learn to Evaluate Moderna Inc. Common Stock (MRNA) using the Charts
- Stock Traders Daily
-
- MarketNewsVideo.com
-
- MarketNewsVideo.com
-
mRNA Vaccine and Therapeutics Market Report 2023, Size, Share, Trends and Forecast to 2028
- SUPER MARKET RESEARCH
-
Moderna Stock Drops as Secures Ebola Vaccine Contract With the U.S
- PressReach.com
-
Moderna Inc. Common Stock MRNA Trading Report
- Stock Traders Daily
-
Moderna Stock Rises on Positive Business Outlook
- PressReach.com
-
Moderna to Acquire OriCiro Genomics
- ACCESSWIRE
-
Moderna Inc. Common Stock MRNA Trading Report
- Stock Traders Daily
-
- MarketNewsVideo.com
-
- MarketNewsVideo.com
-
- MarketNewsVideo.com
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com